Treatment of High Risk Sertoli–Leydig Cell Tumors of the Ovary Using a Gonadotropin Releasing Hormone (GnRH) Analog

Sertoli–Leydig cell tumors are rare ovarian neoplasms. We report two unusual cases with bilateral SLCTs suggesting evidence of genetic predisposition and at high risk of recurrence. To reduce this risk, we exploited the use of GnRH analog to lower gondadotropin and potentially directly inhibit the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lashkari, Harsha Prasada, Nash, Ruth, Albanese, Assunta, Okoye, Bruce, Millar, Robert, Pritchard-Jones, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2013
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744765/
https://www.ncbi.nlm.nih.gov/pubmed/23193086
http://dx.doi.org/10.1002/pbc.24382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744765/
https://www.ncbi.nlm.nih.gov/pubmed/23193086
http://dx.doi.org/10.1002/pbc.24382

Ejemplares similares